tradingkey.logo
搜索

Oncology Institute Inc

TOI
添加自选
4.860USD
-0.210-4.14%
收盘 07-31 16:00美东报价延迟15分钟
485.87M总市值
亏损市盈率 TTM

关于 Oncology Institute Inc 公司

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Oncology Institute Inc简介

公司代码TOI
公司名称Oncology Institute Inc
上市日期Mar 13, 2020
CEOVirnich (Daniel)
员工数量825
证券类型Ordinary Share
年结日Mar 13
公司地址18000 Studebaker Rd
城市CERRITOS
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编90703
电话15627353226
网址https://theoncologyinstitute.com/
公司代码TOI
上市日期Mar 13, 2020
CEOVirnich (Daniel)

Oncology Institute Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--

常见问题

Oncology Institute Inc的前五大股东是谁?

Oncology Institute Inc 的前五大股东如下:Dr. Daniel Virnich, M.D.

有多少机构持有Oncology Institute Inc(TOI)的股份?

截至2026Q1,共有204家机构持有Oncology Institute Inc的股份,合计持有的股份价值约为47.47M,占公司总股份的47.57%。与2025Q4相比,机构持股有所增加,增幅为-10136464.00。

哪个业务部门对Oncology Institute Inc的收入贡献最大?

在2026Q1,Dispensary revenue业务部门对Oncology Institute Inc的收入贡献最大,创收269.18M,占总收入的53.54%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有